HEADER SPLICING 29-OCT-21 7Q4A TITLE TOXOPLASMA GONDII PRP4K KINASE DOMAIN (L715F) BOUND TO ALTIRATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-SPECIFIC SERINE/THREONINE PROTEIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.11.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TOXOPLASMA GONDII; SOURCE 3 ORGANISM_TAXID: 5811; SOURCE 4 GENE: TGGT1_313180; SOURCE 5 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PFASTBAC-1 KEYWDS SPLICEOSOME, KINASE INHIBITOR, SPLICING INHIBITION, SPLICING EXPDTA X-RAY DIFFRACTION AUTHOR C.SWALE,V.BELLINI,M.BOWLER REVDAT 3 31-JAN-24 7Q4A 1 REMARK REVDAT 2 17-AUG-22 7Q4A 1 JRNL REVDAT 1 03-AUG-22 7Q4A 0 JRNL AUTH C.SWALE,V.BELLINI,M.W.BOWLER,N.FLORE,M.P.BRENIER-PINCHART, JRNL AUTH 2 D.CANNELLA,L.BELMUDES,C.MAS,Y.COUTE,F.LAURENT,A.SCHERF, JRNL AUTH 3 A.BOUGDOUR,M.A.HAKIMI JRNL TITL ALTIRATINIB BLOCKS TOXOPLASMA GONDII AND PLASMODIUM JRNL TITL 2 FALCIPARUM DEVELOPMENT BY SELECTIVELY TARGETING A JRNL TITL 3 SPLICEOSOME KINASE. JRNL REF SCI TRANSL MED V. 14 N3231 2022 JRNL REFN ESSN 1946-6242 JRNL PMID 35921477 JRNL DOI 10.1126/SCITRANSLMED.ABN3231 REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.62 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 42233 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.720 REMARK 3 FREE R VALUE TEST SET COUNT : 1995 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.6200 - 5.5700 0.99 3129 156 0.1669 0.1726 REMARK 3 2 5.5600 - 4.4200 1.00 3093 153 0.1588 0.1688 REMARK 3 3 4.4200 - 3.8600 1.00 3093 150 0.1623 0.1822 REMARK 3 4 3.8600 - 3.5100 1.00 3095 156 0.1872 0.1864 REMARK 3 5 3.5100 - 3.2600 0.99 3048 156 0.2265 0.2800 REMARK 3 6 3.2600 - 3.0700 1.00 3082 150 0.2404 0.2355 REMARK 3 7 3.0700 - 2.9100 1.00 3064 153 0.2541 0.2953 REMARK 3 8 2.9100 - 2.7800 1.00 3094 153 0.2712 0.2924 REMARK 3 9 2.7800 - 2.6800 1.00 3064 151 0.2727 0.2817 REMARK 3 10 2.6800 - 2.5900 0.99 3081 153 0.2791 0.2944 REMARK 3 11 2.5900 - 2.5000 1.00 3083 154 0.2790 0.3288 REMARK 3 12 2.5000 - 2.4300 1.00 3013 148 0.3047 0.3210 REMARK 3 13 2.4300 - 2.3700 0.82 2553 123 0.3255 0.3532 REMARK 3 14 2.3700 - 2.3100 0.24 746 39 0.3153 0.3512 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.306 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.803 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.45 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 68.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 5787 REMARK 3 ANGLE : 0.718 7792 REMARK 3 CHIRALITY : 0.043 834 REMARK 3 PLANARITY : 0.004 990 REMARK 3 DIHEDRAL : 18.661 2187 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 20.2427 -29.2132 -7.4415 REMARK 3 T TENSOR REMARK 3 T11: 0.3422 T22: 0.4832 REMARK 3 T33: 0.3167 T12: 0.0719 REMARK 3 T13: 0.0137 T23: -0.0080 REMARK 3 L TENSOR REMARK 3 L11: 0.9934 L22: 1.7642 REMARK 3 L33: 0.5931 L12: 0.5794 REMARK 3 L13: -0.0702 L23: 0.1286 REMARK 3 S TENSOR REMARK 3 S11: 0.0245 S12: -0.1363 S13: 0.0074 REMARK 3 S21: 0.0979 S22: -0.0286 S23: -0.0206 REMARK 3 S31: 0.0624 S32: -0.0128 S33: 0.0121 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7Q4A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-NOV-21. REMARK 100 THE DEPOSITION ID IS D_1292118924. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUN-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : MASSIF-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9655 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45271 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 48.620 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.3700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 37.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.820 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6CNH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG 3350, 0.18 M POTASSIUM REMARK 280 THIOCYANATE, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.24000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 84.36000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.12000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 VAL A 3 REMARK 465 SER A 4 REMARK 465 VAL A 5 REMARK 465 SER A 6 REMARK 465 ALA A 7 REMARK 465 THR A 8 REMARK 465 ALA A 9 REMARK 465 GLY A 10 REMARK 465 PRO A 11 REMARK 465 ALA A 12 REMARK 465 GLU A 13 REMARK 465 ASN A 14 REMARK 465 ASP A 283 REMARK 465 ALA A 284 REMARK 465 PHE A 285 REMARK 465 PHE A 286 REMARK 465 GLN A 311 REMARK 465 HIS A 312 REMARK 465 TRP A 313 REMARK 465 LEU A 314 REMARK 465 LYS A 315 REMARK 465 GLY A 316 REMARK 465 ASN A 317 REMARK 465 SER A 318 REMARK 465 PRO A 319 REMARK 465 HIS A 363 REMARK 465 HIS A 364 REMARK 465 HIS A 365 REMARK 465 HIS A 366 REMARK 465 HIS A 367 REMARK 465 HIS A 368 REMARK 465 HIS A 369 REMARK 465 HIS A 370 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 VAL B 3 REMARK 465 SER B 4 REMARK 465 VAL B 5 REMARK 465 SER B 6 REMARK 465 ALA B 7 REMARK 465 THR B 8 REMARK 465 ALA B 9 REMARK 465 GLY B 10 REMARK 465 PRO B 11 REMARK 465 ALA B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 360 REMARK 465 SER B 361 REMARK 465 ILE B 362 REMARK 465 HIS B 363 REMARK 465 HIS B 364 REMARK 465 HIS B 365 REMARK 465 HIS B 366 REMARK 465 HIS B 367 REMARK 465 HIS B 368 REMARK 465 HIS B 369 REMARK 465 HIS B 370 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 59 60.46 61.88 REMARK 500 ASP A 163 36.94 -145.41 REMARK 500 ASP A 215 -156.32 -138.34 REMARK 500 HIS B 69 87.38 -69.67 REMARK 500 LYS B 133 -147.77 -125.31 REMARK 500 ASP B 163 34.85 -148.73 REMARK 500 VAL B 189 51.39 37.38 REMARK 500 SER B 190 -141.25 -148.83 REMARK 500 ASP B 215 -159.99 -129.41 REMARK 500 ASN B 317 63.44 -100.54 REMARK 500 PRO B 319 -64.45 -15.72 REMARK 500 REMARK 500 REMARK: NULL DBREF 7Q4A A 2 362 UNP S7UT92 S7UT92_TOXGG 534 894 DBREF 7Q4A B 2 362 UNP S7UT92 S7UT92_TOXGG 534 894 SEQADV 7Q4A MET A 1 UNP S7UT92 INITIATING METHIONINE SEQADV 7Q4A SER A 39 UNP S7UT92 CYS 571 CONFLICT SEQADV 7Q4A PHE A 183 UNP S7UT92 LEU 715 CONFLICT SEQADV 7Q4A HIS A 363 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS A 364 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS A 365 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS A 366 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS A 367 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS A 368 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS A 369 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS A 370 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A MET B 1 UNP S7UT92 INITIATING METHIONINE SEQADV 7Q4A SER B 39 UNP S7UT92 CYS 571 CONFLICT SEQADV 7Q4A PHE B 183 UNP S7UT92 LEU 715 CONFLICT SEQADV 7Q4A HIS B 363 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS B 364 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS B 365 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS B 366 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS B 367 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS B 368 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS B 369 UNP S7UT92 EXPRESSION TAG SEQADV 7Q4A HIS B 370 UNP S7UT92 EXPRESSION TAG SEQRES 1 A 370 MET THR VAL SER VAL SER ALA THR ALA GLY PRO ALA GLU SEQRES 2 A 370 ASN TRP ASN ASP SER GLU GLY TYR TYR GLN ALA THR VAL SEQRES 3 A 370 GLY GLU LEU LEU ASP ASP GLY ARG TYR ARG VAL GLU SER SEQRES 4 A 370 GLU ALA ILE GLY LYS GLY VAL PHE SER ASN VAL LEU LYS SEQRES 5 A 370 CYS TYR ASP LEU GLN GLU LYS ARG PHE VAL ALA ILE LYS SEQRES 6 A 370 CYS ILE ARG HIS ASN ASP MET MET LYS LYS ALA ALA GLU SEQRES 7 A 370 LYS GLU THR SER ILE LEU ARG LEU LEU ASN SER THR ASP SEQRES 8 A 370 LYS ASP ASP LYS ARG HIS ILE VAL ARG LEU LEU ARG HIS SEQRES 9 A 370 PHE GLU TYR ARG GLY HIS PHE CYS LEU VAL PHE GLU TRP SEQRES 10 A 370 LEU TRP GLY ASN LEU ARG THR ALA LEU LYS LYS TYR GLY SEQRES 11 A 370 GLY GLY LYS GLY LEU ASN ALA PRO ALA ILE HIS ALA TYR SEQRES 12 A 370 SER LYS GLN LEU PHE VAL ALA LEU LYS HIS LEU SER ARG SEQRES 13 A 370 CYS ARG ILE ILE HIS ALA ASP LEU LYS PRO ASP ASN ILE SEQRES 14 A 370 LEU LEU ASN GLU LYS PHE SER SER LEU LYS VAL CYS ASP SEQRES 15 A 370 PHE GLY SER ALA SER ASP VAL SER ASP ASN GLU ILE THR SEQRES 16 A 370 ALA PTR LEU VAL SER ARG PHE TYR ARG ALA PRO GLU ILE SEQRES 17 A 370 ILE LEU GLY CYS ARG TYR ASP LEU GLN ILE ASP VAL TRP SEQRES 18 A 370 SER ALA ALA ALA THR ILE TYR GLU LEU ALA THR GLY GLN SEQRES 19 A 370 VAL LEU PHE PRO GLY ARG THR ASN ASN ASP MET LEU LYS SEQRES 20 A 370 CYS ILE MET GLU VAL LYS GLY LYS ILE PRO THR LYS MET SEQRES 21 A 370 ILE LYS ALA GLY GLN LEU SER SER HIS HIS PHE ASP GLU SEQRES 22 A 370 ASN LEU ASP PHE ILE TYR ARG ASP ARG ASP ALA PHE PHE SEQRES 23 A 370 LYS LYS GLU VAL THR ARG VAL LEU HIS ASP LEU ARG PRO SEQRES 24 A 370 THR ARG ASN LEU THR GLU ASN LEU ILE GLU LYS GLN HIS SEQRES 25 A 370 TRP LEU LYS GLY ASN SER PRO LYS ILE ASN PHE LEU ARG SEQRES 26 A 370 ARG LYS MET ARG GLN LEU GLY ASP LEU LEU GLU LYS CYS SEQRES 27 A 370 LEU ALA LEU ASP PRO GLN LYS ARG LEU THR PRO ASP GLU SEQRES 28 A 370 ALA LEU GLN HIS PRO PHE LEU LYS GLU SER ILE HIS HIS SEQRES 29 A 370 HIS HIS HIS HIS HIS HIS SEQRES 1 B 370 MET THR VAL SER VAL SER ALA THR ALA GLY PRO ALA GLU SEQRES 2 B 370 ASN TRP ASN ASP SER GLU GLY TYR TYR GLN ALA THR VAL SEQRES 3 B 370 GLY GLU LEU LEU ASP ASP GLY ARG TYR ARG VAL GLU SER SEQRES 4 B 370 GLU ALA ILE GLY LYS GLY VAL PHE SER ASN VAL LEU LYS SEQRES 5 B 370 CYS TYR ASP LEU GLN GLU LYS ARG PHE VAL ALA ILE LYS SEQRES 6 B 370 CYS ILE ARG HIS ASN ASP MET MET LYS LYS ALA ALA GLU SEQRES 7 B 370 LYS GLU THR SER ILE LEU ARG LEU LEU ASN SER THR ASP SEQRES 8 B 370 LYS ASP ASP LYS ARG HIS ILE VAL ARG LEU LEU ARG HIS SEQRES 9 B 370 PHE GLU TYR ARG GLY HIS PHE CYS LEU VAL PHE GLU TRP SEQRES 10 B 370 LEU TRP GLY ASN LEU ARG THR ALA LEU LYS LYS TYR GLY SEQRES 11 B 370 GLY GLY LYS GLY LEU ASN ALA PRO ALA ILE HIS ALA TYR SEQRES 12 B 370 SER LYS GLN LEU PHE VAL ALA LEU LYS HIS LEU SER ARG SEQRES 13 B 370 CYS ARG ILE ILE HIS ALA ASP LEU LYS PRO ASP ASN ILE SEQRES 14 B 370 LEU LEU ASN GLU LYS PHE SER SER LEU LYS VAL CYS ASP SEQRES 15 B 370 PHE GLY SER ALA SER ASP VAL SER ASP ASN GLU ILE THR SEQRES 16 B 370 ALA PTR LEU VAL SER ARG PHE TYR ARG ALA PRO GLU ILE SEQRES 17 B 370 ILE LEU GLY CYS ARG TYR ASP LEU GLN ILE ASP VAL TRP SEQRES 18 B 370 SER ALA ALA ALA THR ILE TYR GLU LEU ALA THR GLY GLN SEQRES 19 B 370 VAL LEU PHE PRO GLY ARG THR ASN ASN ASP MET LEU LYS SEQRES 20 B 370 CYS ILE MET GLU VAL LYS GLY LYS ILE PRO THR LYS MET SEQRES 21 B 370 ILE LYS ALA GLY GLN LEU SER SER HIS HIS PHE ASP GLU SEQRES 22 B 370 ASN LEU ASP PHE ILE TYR ARG ASP ARG ASP ALA PHE PHE SEQRES 23 B 370 LYS LYS GLU VAL THR ARG VAL LEU HIS ASP LEU ARG PRO SEQRES 24 B 370 THR ARG ASN LEU THR GLU ASN LEU ILE GLU LYS GLN HIS SEQRES 25 B 370 TRP LEU LYS GLY ASN SER PRO LYS ILE ASN PHE LEU ARG SEQRES 26 B 370 ARG LYS MET ARG GLN LEU GLY ASP LEU LEU GLU LYS CYS SEQRES 27 B 370 LEU ALA LEU ASP PRO GLN LYS ARG LEU THR PRO ASP GLU SEQRES 28 B 370 ALA LEU GLN HIS PRO PHE LEU LYS GLU SER ILE HIS HIS SEQRES 29 B 370 HIS HIS HIS HIS HIS HIS MODRES 7Q4A PTR A 197 TYR MODIFIED RESIDUE MODRES 7Q4A PTR B 197 TYR MODIFIED RESIDUE HET PTR A 197 16 HET PTR B 197 16 HET A9I A 401 37 HET GOL A 402 14 HET PEG A 403 7 HET A9I B 401 37 HET SCN B 402 3 HETNAM PTR O-PHOSPHOTYROSINE HETNAM A9I ALTIRATINIB HETNAM GOL GLYCEROL HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM SCN THIOCYANATE ION HETSYN PTR PHOSPHONOTYROSINE HETSYN A9I N-1'-[4-[2-(CYCLOPROPYLCARBONYLAMINO)PYRIDIN-4-YL]OXY- HETSYN 2 A9I 2,5-BIS(FLUORANYL)PHENYL]-N-1-(4-FLUOROPHENYL) HETSYN 3 A9I CYCLOPROPANE-1,1-DICARBOXAMIDE; 1-N'-[4-[2- HETSYN 4 A9I (CYCLOPROPANECARBONYLAMINO)PYRIDIN-4-YL]OXY-2,5- HETSYN 5 A9I DIFLUOROPHENYL]-1-N-(4-FLUOROPHENYL)CYCLOPROPANE-1,1- HETSYN 6 A9I DICARBOXAMIDE; N-[4-[[2-[(CYCLOPROPYLCARBONYL)AMINO]- HETSYN 7 A9I 4-PYRIDINYL]OXY]-2,5-DIFLUOROPHENYL]-N'-(4- HETSYN 8 A9I FLUOROPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 A9I 2(C26 H21 F3 N4 O4) FORMUL 4 GOL C3 H8 O3 FORMUL 5 PEG C4 H10 O3 FORMUL 7 SCN C N S 1- FORMUL 8 HOH *22(H2 O) HELIX 1 AA1 ASN A 70 THR A 90 1 21 HELIX 2 AA2 LEU A 122 GLY A 130 1 9 HELIX 3 AA3 ASN A 136 CYS A 157 1 22 HELIX 4 AA4 LYS A 165 ASP A 167 5 3 HELIX 5 AA5 VAL A 189 GLU A 193 5 5 HELIX 6 AA6 THR A 195 PHE A 202 1 8 HELIX 7 AA7 ALA A 205 LEU A 210 1 6 HELIX 8 AA8 LEU A 216 GLY A 233 1 18 HELIX 9 AA9 THR A 241 GLY A 254 1 14 HELIX 10 AB1 PRO A 257 GLY A 264 1 8 HELIX 11 AB2 LEU A 266 HIS A 270 5 5 HELIX 12 AB3 ASN A 302 LYS A 310 1 9 HELIX 13 AB4 ILE A 321 LEU A 339 1 19 HELIX 14 AB5 THR A 348 GLN A 354 1 7 HELIX 15 AB6 HIS A 355 GLU A 360 1 6 HELIX 16 AB7 ASN B 70 THR B 90 1 21 HELIX 17 AB8 LEU B 122 GLY B 130 1 9 HELIX 18 AB9 ASN B 136 CYS B 157 1 22 HELIX 19 AC1 LYS B 165 ASP B 167 5 3 HELIX 20 AC2 PHE B 183 ASP B 188 5 6 HELIX 21 AC3 GLU B 193 ARG B 201 1 9 HELIX 22 AC4 PHE B 202 ARG B 204 5 3 HELIX 23 AC5 ALA B 205 LEU B 210 1 6 HELIX 24 AC6 LEU B 216 GLY B 233 1 18 HELIX 25 AC7 THR B 241 GLY B 254 1 14 HELIX 26 AC8 PRO B 257 GLY B 264 1 8 HELIX 27 AC9 LEU B 266 HIS B 270 5 5 HELIX 28 AD1 ASN B 302 LYS B 310 1 9 HELIX 29 AD2 PRO B 319 LEU B 339 1 21 HELIX 30 AD3 THR B 348 GLN B 354 1 7 SHEET 1 AA1 4 LEU A 29 LEU A 30 0 SHEET 2 AA1 4 TYR A 35 VAL A 37 -1 O TYR A 35 N LEU A 30 SHEET 3 AA1 4 SER A 48 ASP A 55 -1 O TYR A 54 N ARG A 36 SHEET 4 AA1 4 GLY A 43 LYS A 44 -1 N GLY A 43 O VAL A 50 SHEET 1 AA2 6 LEU A 29 LEU A 30 0 SHEET 2 AA2 6 TYR A 35 VAL A 37 -1 O TYR A 35 N LEU A 30 SHEET 3 AA2 6 SER A 48 ASP A 55 -1 O TYR A 54 N ARG A 36 SHEET 4 AA2 6 ARG A 60 ILE A 67 -1 O VAL A 62 N CYS A 53 SHEET 5 AA2 6 HIS A 110 GLU A 116 -1 O PHE A 115 N ALA A 63 SHEET 6 AA2 6 LEU A 101 TYR A 107 -1 N PHE A 105 O CYS A 112 SHEET 1 AA3 3 GLY A 120 ASN A 121 0 SHEET 2 AA3 3 ILE A 169 LEU A 171 -1 O LEU A 171 N GLY A 120 SHEET 3 AA3 3 LEU A 178 VAL A 180 -1 O LYS A 179 N LEU A 170 SHEET 1 AA4 2 PHE A 277 TYR A 279 0 SHEET 2 AA4 2 ARG A 292 LEU A 294 -1 O ARG A 292 N TYR A 279 SHEET 1 AA5 4 LEU B 29 LEU B 30 0 SHEET 2 AA5 4 TYR B 35 VAL B 37 -1 O TYR B 35 N LEU B 30 SHEET 3 AA5 4 SER B 48 ASP B 55 -1 O TYR B 54 N ARG B 36 SHEET 4 AA5 4 GLY B 43 LYS B 44 -1 N GLY B 43 O VAL B 50 SHEET 1 AA6 6 LEU B 29 LEU B 30 0 SHEET 2 AA6 6 TYR B 35 VAL B 37 -1 O TYR B 35 N LEU B 30 SHEET 3 AA6 6 SER B 48 ASP B 55 -1 O TYR B 54 N ARG B 36 SHEET 4 AA6 6 ARG B 60 ILE B 67 -1 O ARG B 60 N ASP B 55 SHEET 5 AA6 6 HIS B 110 GLU B 116 -1 O PHE B 115 N ALA B 63 SHEET 6 AA6 6 LEU B 101 TYR B 107 -1 N LEU B 102 O VAL B 114 SHEET 1 AA7 3 GLY B 120 ASN B 121 0 SHEET 2 AA7 3 ILE B 169 LEU B 171 -1 O LEU B 171 N GLY B 120 SHEET 3 AA7 3 LEU B 178 VAL B 180 -1 O LYS B 179 N LEU B 170 SHEET 1 AA8 2 PHE B 277 TYR B 279 0 SHEET 2 AA8 2 ARG B 292 LEU B 294 -1 O ARG B 292 N TYR B 279 LINK C ALA A 196 N PTR A 197 1555 1555 1.33 LINK C PTR A 197 N LEU A 198 1555 1555 1.33 LINK C ALA B 196 N PTR B 197 1555 1555 1.33 LINK C PTR B 197 N LEU B 198 1555 1555 1.33 CRYST1 96.771 96.771 112.480 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010334 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010334 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008890 0.00000